The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Moderna with a $147.08 average price target, implying a 19.8% upside from current levels. In a report issued on January 5, Merrill Lynch also maintained a Hold rating on the stock with a $130.00 price target.
No comments:
Post a Comment